Invst LLC Takes Position in Philip Morris International Inc. $PM

Invst LLC purchased a new stake in Philip Morris International Inc. (NYSE:PM) during the second quarter, Holdings Channel reports. The institutional investor purchased 4,681 shares of the company’s stock, valued at approximately $847,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Brighton Jones LLC raised its position in Philip Morris International by 31.1% during the fourth quarter. Brighton Jones LLC now owns 8,531 shares of the company’s stock worth $1,027,000 after acquiring an additional 2,023 shares during the period. Revolve Wealth Partners LLC grew its position in shares of Philip Morris International by 4.5% in the fourth quarter. Revolve Wealth Partners LLC now owns 2,097 shares of the company’s stock valued at $252,000 after purchasing an additional 91 shares during the period. Sivia Capital Partners LLC increased its stake in shares of Philip Morris International by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 5,636 shares of the company’s stock worth $1,027,000 after purchasing an additional 1,970 shares in the last quarter. Jump Financial LLC purchased a new stake in shares of Philip Morris International during the second quarter worth about $2,454,000. Finally, Osterweis Capital Management Inc. raised its position in shares of Philip Morris International by 2,280.0% during the 2nd quarter. Osterweis Capital Management Inc. now owns 357 shares of the company’s stock worth $65,000 after purchasing an additional 342 shares during the last quarter. Institutional investors and hedge funds own 78.63% of the company’s stock.

Philip Morris International Stock Up 1.3%

Shares of NYSE PM opened at $194.00 on Wednesday. The firm has a 50-day simple moving average of $186.42 and a 200-day simple moving average of $178.55. The stock has a market capitalization of $302.36 billion, a price-to-earnings ratio of 27.87, a price-to-earnings-growth ratio of 2.31 and a beta of 0.38. Philip Morris International Inc. has a 52 week low of $142.11 and a 52 week high of $207.76.

Philip Morris International (NYSE:PM) last posted its quarterly earnings results on Wednesday, July 22nd. The company reported $2.20 earnings per share for the quarter, topping the consensus estimate of $2.05 by $0.15. The firm had revenue of $11.19 billion for the quarter, compared to the consensus estimate of $10.60 billion. Philip Morris International had a net margin of 11.06% and a negative return on equity of 163.41%. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the firm posted $1.89 earnings per share. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. As a group, equities research analysts expect that Philip Morris International Inc. will post 8.33 EPS for the current year.

Philip Morris International Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, July 20th. Shareholders of record on Thursday, June 25th were paid a $1.47 dividend. This represents a $5.88 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend was Thursday, June 25th. Philip Morris International’s dividend payout ratio (DPR) is 84.48%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Bank of America reaffirmed a “buy” rating on shares of Philip Morris International in a research note on Thursday, May 21st. Needham & Company LLC boosted their price objective on Philip Morris International from $200.00 to $215.00 and gave the stock a “buy” rating in a research note on Thursday, July 23rd. Weiss Ratings reissued a “buy (b)” rating on shares of Philip Morris International in a report on Monday, August 17th. UBS Group raised their target price on Philip Morris International from $168.00 to $182.00 and gave the company a “neutral” rating in a research report on Thursday, July 2nd. Finally, Citigroup lifted their price target on Philip Morris International from $210.00 to $225.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Ten equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $205.89.

Philip Morris International News Summary

Here are the key news stories impacting Philip Morris International this week:

• Positive Sentiment: FDA authorization strengthens ZYN growth prospects. The FDA authorized 11 ZYN ULTRA nicotine-pouch products, expanding PM’s U.S. smoke-free portfolio and supporting its longer-term shift away from combustible tobacco. Smoke-free products, led by ZYN and IQOS, now account for more than 41% of revenue, offering a potential multiyear growth runway. Philip Morris’ ZYN ULTRA FDA Authorization Strengthens Smoke-Free Push
• Positive Sentiment: Manufacturing agreements with Altria may improve efficiency. PM and Altria entered reciprocal contract-manufacturing arrangements involving cigarette production. The agreements should increase operational flexibility and manufacturing efficiency, with initial shipments expected in 2027. The partnership may provide longer-term cost and supply-chain benefits for PM, despite limited near-term earnings impact. Altria and Philip Morris International Sign Contract Manufacturing Deals
• Positive Sentiment: Pricing power and shareholder returns remain supportive. PM’s portfolio spans IQOS, ZYN, VEEV One, and Marlboro, helping it maintain premium pricing amid uncertain economic conditions. Analysts highlight strong free cash flow, lower debt leverage, and the possibility of another dividend increase in September. Philip Morris: Big Tobacco With High-Growth Smoke-Free Assets
• Neutral Sentiment: Near-term financial impact from the Altria deal is expected to be limited. Both companies said the manufacturing arrangements are not expected to materially affect 2026 results, so investors may need to wait until 2027 for measurable benefits. Altria vs. Philip Morris: What the New Manufacturing Deal Means for Investors
• Negative Sentiment: Valuation leaves less room for disappointment. PM’s smoke-free growth and defensive cash flows have attracted a premium valuation, creating downside risk if product adoption, regulatory momentum, or earnings growth falls short of expectations.

Philip Morris International Company Profile

Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.

PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.